These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

199 related items for PubMed ID: 8136810

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Polyarthritis following intravesical BCG immunotherapy. Report of a case and review of 26 cases in the literature.
    Clavel G, Grados F, Cayrolle G, Bellony R, Leduc I, Lafont B, Ducroix JP, Fardellone P.
    Rev Rhum Engl Ed; 1999 Feb; 66(2):115-8. PubMed ID: 10084173
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Reiter syndrome after intravesical Bacillus Calmette-Guerin (BCG) immunotherapy: a case report].
    Shiba M, Fujii T, Takatera H.
    Hinyokika Kiyo; 2003 Oct; 49(10):599-601. PubMed ID: 14655604
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [BCG infection of the glans penis after intravesical BCG therapy].
    Michelet N, Spenatto N, Viraben R, Cuny JF, Mazet J, Trechot P, Barbaud A, Schmutz JL.
    Ann Dermatol Venereol; 2008 Oct; 135(6-7):479-83. PubMed ID: 18598797
    [Abstract] [Full Text] [Related]

  • 9. [Intravesical immunotherapy of in situ carcinoma of the urinary bladder using Bacillus Calmette-Guerin (BCG)].
    Jakse G.
    Wien Klin Wochenschr; 1987 Feb 20; 99(4):114-8. PubMed ID: 3577186
    [Abstract] [Full Text] [Related]

  • 10. Systemic bacillus Calmette-Guerin infection in patients treated by intravesical BCG therapy for superficial bladder cancer.
    Steg A, Leleu C, Debré B, Boccon-Gibod L, Sicard D.
    Prog Clin Biol Res; 1989 Feb 20; 310():325-34. PubMed ID: 2672020
    [Abstract] [Full Text] [Related]

  • 11. Adverse drug reactions of intravesical bacillus Calmette-Guerin instillation and risk factors of the development of adverse drug reactions in superficial cancer and carcinoma in situ of the bladder.
    Koga H, Kuroda M, Kudo S, Yamaguchi A, Usami M, Suzuki T, Naito S.
    Int J Urol; 2005 Feb 20; 12(2):145-51. PubMed ID: 15733108
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Intravesical Bacillus Calmette-Guerin (BCG: Tokyo 172 strain) instillation for carcinoma in situ of the bladder: results with 6 successive instillations of 40 mg BCG].
    Mugiya S, Nagata M, Takayama T, Ozono S, Ito T, Maruyama S, Hadano S, Nagae H.
    Hinyokika Kiyo; 2004 Jul 20; 50(7):469-73. PubMed ID: 15334890
    [Abstract] [Full Text] [Related]

  • 15. Does isoniazid reduce side effects of intravesical bacillus Calmette-Guerin therapy in superficial bladder cancer? Interim results of European Organization for Research and Treatment of Cancer Protocol 30911.
    Vegt PD, van der Meijden AP, Sylvester R, Brausi M, Höltl W, de Balincourt C.
    J Urol; 1997 Apr 20; 157(4):1246-9. PubMed ID: 9120912
    [Abstract] [Full Text] [Related]

  • 16. Immunoprophylactic intravesical application of bacillus Calmette-Guerin after transurethral resection of superficial bladder cancer.
    Librenjak D, Situm M, Eterovic D, Dogas Z, Gotovac J.
    Croat Med J; 2003 Apr 20; 44(2):187-92. PubMed ID: 12698510
    [Abstract] [Full Text] [Related]

  • 17. [Intravesical instillations of BCG and bladder carcinoma in situ].
    Haab F, Dauge MC, Delmas V, Boccon-Gibod L.
    Prog Urol; 1993 Dec 20; 3(6):988-94; discussion 992-3. PubMed ID: 8305942
    [Abstract] [Full Text] [Related]

  • 18. Intravesical bacillus Calmette-Guerin therapy for stage T1 grade 3 transitional cell carcinoma of the bladder: recurrence, progression and survival in a study of 57 patients.
    Peyromaure M, Guerin F, Amsellem-Ouazana D, Saighi D, Debre B, Zerbib M.
    J Urol; 2003 Jun 20; 169(6):2110-2. PubMed ID: 12771729
    [Abstract] [Full Text] [Related]

  • 19. Chorioretinitis induced by intravesical Bacillus Calmette-Guérin (BCG) instillations for urinary bladder carcinoma.
    Guex-Crosier Y, Chamot L, Zografos L.
    Klin Monbl Augenheilkd; 2003 Mar 20; 220(3):193-5. PubMed ID: 12664378
    [Abstract] [Full Text] [Related]

  • 20. [Two cases of successful treatments with steroid for local and systemic hypersensitivity reaction following intravesical instillation of Bacillus Calmette-Guerin].
    Shimasaki N, Yamasaki I, Kamada M, Syuin T.
    Hinyokika Kiyo; 2001 Apr 20; 47(4):281-4. PubMed ID: 11411106
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.